DUES Measurement for Research Purposes
I cannot provide specific guidance on measuring "DUES" (Drug Use and Effects Survey) for research purposes, as none of the provided evidence directly addresses this specific instrument or measurement tool.
What the Evidence Does Address
The provided guidelines and research focus on related but distinct measurement approaches in substance use research:
Primary Substance Use Outcome Measures
For research purposes, biological verification combined with standardized self-report represents the gold standard approach to measuring drug consumption. 1
- Biological markers should be assessed repeatedly according to dissipation rates: carbon monoxide (hours), cotinine (up to one week), cocaine metabolites (24-48 hours standard, up to 22 days in heavy users), opioid metabolites (variable by compound) 1, 2
- Timeline Follow-Back (TLFB) interview is the gold standard self-report method for assessing days of use over a defined period (typically 30 days), though it relies entirely on self-report 1
- Hierarchical outcome selection for effect size estimation: (1) biological assay measures, (2) frequency/quantity measures with means and standard deviations, (3) sample proportions, (4) other outcomes like diagnostic measures 1
Adherence Measurement in Clinical Trials
- Electronic detection of package entry (MEMS®) provides 97% accuracy between package opening and dose ingestion, allowing precise identification of initiation, implementation, and persistence 1
- Multiple complementary measures should each measure distinct elements of adherence (initiation, implementation, persistence) rather than triangulating the same construct 1
Surrogate Endpoints in Substance Use Research
- Cue-reactivity and self-reported craving are the most common dependent measures in brain stimulation studies for substance use disorders, though biological markers of cue-sensitivity relate more closely to relapse than subjective craving 1
- Minimum 3-month follow-up period recommended for longitudinal substance use studies 1
Critical Gap
If DUES refers to a specific validated instrument for measuring drug use and effects, you would need to consult the original instrument development literature or validation studies that are not included in the provided evidence base. The evidence provided focuses on general principles of substance use measurement rather than this specific tool.